LRRK2 and Parkinson disease: In summary, we found increased Rab12 phosphorylation and localization of pS106-Rab12 to tau and α-synuclein pathology in tauopathies and synucleinopathies, including LRRK2 PD, iPD, DLB, AD and primary tauopathies.